Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Incidence of pediatric atopic dermatitis following thymectomy: A Danish register study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. 17q21 variant increases the risk of exacerbations in asthmatic children despite inhaled corticosteroids use

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Neonates colonized with pathogenic bacteria in the airways have a low-grade systemic inflammation

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. EAACI guidelines on allergen immunotherapy: Executive statement

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Local recurrence rate in a national Danish patient cohort after curative treatment for rectal cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Circulating allergen-specific T2 lymphocytes: CCR4rather than CLAis the predominant phenotype in peanut-allergic subjects

    Research output: Contribution to journalComment/debateResearchpeer-review

  3. Clinical relevance of sensitization to hydrolyzed wheat protein in wheat-sensitized subjects

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Food allergy: setting the scene for tolerance induction

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Association between perfluoroalkyl substance exposure and asthma and allergic disease in children as modified by MMR vaccination

    Research output: Contribution to journalJournal articleResearchpeer-review

  • G B Pajno
  • M Fernandez-Rivas
  • S Arasi
  • G Roberts
  • C A Akdis
  • M Alvaro-Lozano
  • K Beyer
  • C Bindslev-Jensen
  • W Burks
  • M Ebisawa
  • P Eigenmann
  • E Knol
  • K C Nadeau
  • L K Poulsen
  • R van Ree
  • A F Santos
  • G du Toit
  • S Dhami
  • U Nurmatov
  • Y Boloh
  • M Makela
  • L O'Mahony
  • N Papadopoulos
  • C Sackesen
  • I Agache
  • E Angier
  • S Halken
  • M Jutel
  • S Lau
  • O Pfaar
  • D Ryan
  • G Sturm
  • E-M Varga
  • R G van Wijk
  • A Sheikh
  • A Muraro
  • EAACI Allergen Immunotherapy Guidelines Group
View graph of relations

Food allergy can result in considerable morbidity, impairment of quality of life, and healthcare expenditure. There is therefore interest in novel strategies for its treatment, particularly food allergen immunotherapy (FA-AIT) through the oral (OIT), sublingual (SLIT), or epicutaneous (EPIT) routes. This Guideline, prepared by the European Academy of Allergy and Clinical Immunology (EAACI) Task Force on Allergen Immunotherapy for IgE-mediated Food Allergy, aims to provide evidence-based recommendations for active treatment of IgE-mediated food allergy with FA-AIT. Immunotherapy relies on the delivery of gradually increasing doses of specific allergen to increase the threshold of reaction while on therapy (also known as desensitization) and ultimately to achieve post-discontinuation effectiveness (also known as tolerance or sustained unresponsiveness). Oral FA-AIT has most frequently been assessed: here, the allergen is either immediately swallowed (OIT) or held under the tongue for a period of time (SLIT). Overall, trials have found substantial benefit for patients undergoing either OIT or SLIT with respect to efficacy during treatment, particularly for cow's milk, hen's egg, and peanut allergies. A benefit post-discontinuation is also suggested, but not confirmed. Adverse events during FA-AIT have been frequently reported, but few subjects discontinue FA-AIT as a result of these. Taking into account the current evidence, FA-AIT should only be performed in research centers or in clinical centers with an extensive experience in FA-AIT. Patients and their families should be provided with information about the use of FA-AIT for IgE-mediated food allergy to allow them to make an informed decision about the therapy.

Original languageEnglish
Article number4
JournalAllergy
VolumeVolume 73
Issue numberIssue4
Pages (from-to)Pages 799-815
Number of pages16
ISSN0105-4538
DOIs
Publication statusPublished - Apr 2018

    Research areas

  • Journal Article

ID: 52696551